Literature DB >> 35895356

Assessment of the Quality of Injectable Antibiotics in Benin.

Angèle Modupè Dohou1,2, Achille Loconon Yémoa2, Dodji Boris Aurel Guidan2, Seyive Hélène Solange Ahouandjinou3, Ahmed Amoussa2, Francis Moïse Dossou4, Roland Marini Djang'eing'a5, Olivia Dalleur1,6.   

Abstract

Substandard and falsified medicines are an enormous threat to global health. Poor quality antibiotic preparations contribute to the development of antimicrobial resistance. In surgery, where the occurrence of healthcare-associated infections is high, healthcare teams need to rely on the quality of antibiotic prophylaxis to prevent infections. We assessed the quality of antibiotics used for surgical infection prophylaxis in Benin. Thirty-three samples were collected from six hospitals located in various departments in Benin. The antibiotics (powders for injection: amoxicillin + clavulanic acid, ampicillin, ceftriaxone; solutions for injection: ciprofloxacin, gentamicin, metronidazole) were assessed using visual inspection, pharmacotechnical tests (including uniformity of mass, pH measure, sterility test, and active pharmaceutical ingredient identification), and assay tests (including a simple analytical method thin layer chromatography) and complex analytical techniques (ultraviolet-visible spectrophotometry, high-performance liquid chromatography-diode-array detection, conductometry). Because the material needed for the methods recommended by the pharmacopeias to assess the dosage of gentamicin was not available, we developed and validated a conductometry method. Results showed that 97% (n = 32) of the samples passed visual inspection; 100% (n = 33) of the samples passed the pharmacotechnical tests, identification of active ingredients, and sterility test; 88% (n = 29) passed the test for percentage of active pharmaceutical ingredients. Overall, 15% of the samples did not pass the quality test (3% on visual inspection and 12% for excess active ingredients). Although most of the samples passed the quality tests, it appears important to perform routine quality control for intravenous medicines.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35895356      PMCID: PMC9294693          DOI: 10.4269/ajtmh.21-0844

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  16 in total

Review 1.  Update on counterfeit antibiotics worldwide; public health risks.

Authors:  A Delepierre; A Gayot; A Carpentier
Journal:  Med Mal Infect       Date:  2012-05-22       Impact factor: 2.152

Review 2.  Healthcare-associated infections in sub-Saharan Africa.

Authors:  C Rothe; C Schlaich; S Thompson
Journal:  J Hosp Infect       Date:  2013-10-02       Impact factor: 3.926

3.  [Quality control of antibiotics used in Senegal].

Authors:  A Diop; S O Sarr; Y M Diop; B Ndiaye; M Fall; G Mbaye
Journal:  Med Trop (Mars)       Date:  2009-06

Review 4.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical Techniques.

Authors:  Achille Yemoa; Vedaste Habyalimana; Jeremie K Mbinze; Victoria Crickboom; Benjamin Muhigirwa; Agnes Ngoya; Pierre-Yves Sacre; Fernand Gbaguidi; Joelle Quetin-Leclercq; Philippe Hubert; Roland D Marini
Journal:  Curr Drug Saf       Date:  2017

6.  Fatal Bacterial Meningitis Possibly Associated with Substandard Ceftriaxone--Uganda, 2013.

Authors:  Jason W Nickerson; Amir Attaran; Brian D Westerberg; Sharon Curtis; Sean Overton; Paul Mayer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-01-01       Impact factor: 17.586

Review 7.  The health consequences of falsified medicines- A study of the published literature.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Naoki Tomizu; Jamie Endo; Onishi Miyu; Yoshio Akimoto; Kazuko Kimura
Journal:  Trop Med Int Health       Date:  2018-10-22       Impact factor: 2.622

8.  Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.

Authors:  Simon Schäfermann; Cathrin Hauk; Emmanuel Wemakor; Richard Neci; Georges Mutombo; Edward Ngah Ndze; Tambo Cletus; Fidelis Nyaah; Manyi Pattinora; Dorothee Wistuba; Irina Helmle; Christine Häfele-Abah; Harald Gross; Lutz Heide
Journal:  Am J Trop Med Hyg       Date:  2020-05-07       Impact factor: 2.345

9.  Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington
Journal:  JAMA Netw Open       Date:  2018-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.